Hangzhou Nutrition Biotechnology Co., Ltd. RN
Hangzhou Nutrition Biotechnology Co., Ltd. RN is a Chinese biotechnical exporter located in Hangzhou, China. Established in 2009, the company operates with an annual capacity focused on collagen products and enteral nutrition (EN) products, targeting markets globally. The business emphasizes its robust research and development capabilities, including a dedicated department that leverages years of industry experience to advance product formulation and application.
The company highlights its collaboration with affiliate entities such as D-BASE and HILMAR MEIJI, indicating a networked approach to product development and commercialization. A notable government-supported initiative in 2012 supported the fish collagen peptide technology as a key project, underscoring the organization’s involvement in innovation within its sector.
Manufacturing operations include dedicated workshops for collagen-related products and EN formulations. Reported production capacity includes around 500 tons for fish collagen powder and about 300 tons for enteral nutrition products. The product portfolio encompasses bulk hydrolyzed collagen powder, fish collagen peptide, collagen granules, and EN powders such as mixed branched-chain amino acid formulas, dietary fiber formulations, and mixed vitamin powders.
Quality and safety are emphasized through certifications and compliance with industry standards. Hangzhou Nutrition Biotechnology Co., Ltd. RN holds QS, HACCP, ISO 22000, HALAL, and CIQ certifications, reflecting adherence to quality management, safety, and regulatory obligations. The company also offers OEM services for various fish collagen products, including canning, stripe, satchel, capsule, tablet, and beverage formats, indicating flexibility in manufacturing solutions for partners and customers.
The company maintains a reputation in China’s medical landscape, with its products used by top-tier hospitals such as Peking Union Medical College Hospital, West China Hospital, The First Affiliated Hospital of Sun Yat-sen University, and The Second Affiliated Hospital of Zhejiang University School of Medicine. With approximately a 15% share of the medical foods market, Hangzhou Nutrition Biotechnology Co., Ltd. RN positions itself for continued growth, supported by ongoing R&D and market expansion efforts.
Overall, the organization presents itself as a research-driven biotechnology exporter with a focus on collagen and EN products, supported by a network of affiliates, government-backed innovation initiatives, and a commitment to quality and OEM manufacturing capabilities.
